Isaac Galatzer-Levy, PhD, assistant professor in psychiatry and bioinformatics, NYU School of Medicine, and vice president of clinical and computational neuroscience, AiCure, said that technological solutions like artificial intelligence can help identify and monitor signs of mental illness so patients can be connected with the help they need.
Isaac Galatzer-Levy, PhD, assistant professor in psychiatry and bioinformatics, NYU School of Medicine, and vice president of clinical and computational neuroscience, AiCure, said that technological solutions like artificial intelligence (AI) can help identify and monitor signs of mental illness so patients can be connected with the help they need.
Transcript
What are some future avenues in psychiatry that could be addressed using AI/machine learning?
Where I think the largest unmet need is in how we actually define and track people with mental health issues. So, what does it mean to be mentally ill? How can we see that out in the wild? How can we see when a patient is not doing well, such that we can intervene to really reduce the hard outcomes that affect their lives?
So I’ll give you an example: If you think about patients with schizophrenia or bipolar disorder or even depression, their disorders really have a cyclic nature to them where, yes, they’re sick and they need to be maintained on medication, but they have episodes that are particularly acute that have huge negative consequences in their life, lead to hospitalization, which really derails multiple aspects of their life and is very hard to come back from.
So I think that there’s a huge opportunity for technology to spot that risk early on to close the loop in terms of interventions and really move both treatment and monitoring outside of the hospital system and into the world. If we can spot patients when they’re doing poorly early on, we can intervene with them and help them. There’s actually an enormous amount of resources available to do that; we’re just not able to link the resources with the people who need them. And I see technology being a real way to achieve that.
I think that the role that AI in particular can play is in how do we actually monitor and understand how a patient is doing. So most of the work that I do right now at AiCure but also in my lab at NYU is focused on how do we identify signals of mental health functioning based on facial recognition, voice, and speech.
So if you think about a patient with depression, there’s a clear signal for what a depressed patient looks like. They talk slowly, they show a lot of negative affect on their face, they use a lot of negative content in their speech, so can we capture that kind of information and understand how a patient is doing on a day-to-day basis, and then intervene when necessary or even deploy treatments as necessary.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More